Conservative treatment of placenta accreta;Placenta accreta: Place du traitement conservateur

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 32, Issue 6, 2003, Pages 549-554

  Courbiere B ^a   Bretelle, F ^a   Porcu, G ^a   Gamerre, M ^a   Blanc, B ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Bilateral hypogastric artery ligation; Conservative treatment; Methotrexate; Placenta accreta

Indexed keywords

METHOTREXATE;

ADULT; ARTERY LIGATION; BILATERAL HYPOGASTRIC ARTERY LIGATION; BLOOD TRANSFUSION; CESAREAN SECTION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CURETTAGE; DELIVERY; ENDOMETRIOSIS; ENDOUTERINE SURGERY; FEMALE; FEMALE FERTILITY; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; INTERNAL ILIAC ARTERY; MATERNAL MORTALITY; MORBIDITY; PLACENTA ACCRETA; PLACENTA PREVIA; POSTOPERATIVE COMPLICATION; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; TISSUE NECROSIS; TREATMENT FAILURE; UTERINE ARTERY EMBOLIZATION; UTERINE NECROSIS; UTERUS BLEEDING; UTERUS SURGERY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; ARTERIES; EMBOLIZATION, THERAPEUTIC; FEMALE; FRANCE; HUMANS; HYSTERECTOMY; INCIDENCE; LIGATION; METHOTREXATE; PLACENTA ACCRETA; POSTPARTUM HEMORRHAGE; PREGNANCY; RETROSPECTIVE STUDIES; STOMACH; TREATMENT OUTCOME; UTERUS;

EID: 0142215220     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta praevia-placenta accreta. Am J Obstet Gynecol 1997; 177: 210-4.
2. Robertson WB, Brosens I, Landells WN. Abnormal placentation. Obstet Gynecol Ann 1985; 14: 411-26.
3. ACOG committee opinion. Placenta accreta. Number 266, january 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 77-8.
4. Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980; 56: 31-4.
5. To WW, Leung WC. Placenta previa and previous cesarean section. Int J Gynaecol Obstet 1995; 51: 25-31.
6. Ota Y, Watanabe H, Pukasawa I, Tanaka S, Kawatsu T, Oishi A et al. Placenta accreta/increta. Review of 10 cases and a case report. Arch Gynecol Obstet 1999; 263: 69-72.
7. Rosemond RL, Kepple DM. Transvaginal color doppler in the prenatal diagnosis of placenta accreta. Obstet Gynecol 1992; 80: 508-10.
8. de Mendonça LK. Sonographic diagnosis of placenta accreta: Presentation of six cases. J Ultrasound Med 1988; 7: 211-5.
9. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000; 15: 28-35.
10. Thorp JM, Councell B, Sandridge DA, Wiest HH. Antepartum diagnosis of placenta previa percreta by Magnetic Resonance Imaging. Obstet Gynecol 1992; 80: 506-8.
11. Fox H. Placenta accreta, 1945-1969. Obstet Gynecol Surv 1972; 27: 475-90.
12. Komulainen MH, Varynen MA, Kauko ML, Saariskoski S. Two cases of placenta accreta managed conservatively. Eur J Obstet Gynecol Reprod Biol 1995; 62: 135-7.
13. Legro RS, Price FV, Hill LM, Caritis SN. Non surgical management of placenta accreta: a case report. Obstet Gynecol 1994; 83: 847-9.
14. Gibb DMF, Soothill PW, Ward KJ. Conservative management of placenta accreta. Br J Obstet Gynaecol 1994; 101: 79-80.
15. Arulkumaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand 1986; 65: 285-6.
16. Scarantino SE, Reilly JG, Moretti MB, Pillari VT. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999; 94: 825-7.
17. Riggs JC, Jahshan A, Schiavello HJ. Alternative conservative management of placenta accreta. A case report. J Reprod Med 2000; 45: 595-8.
18. Salvat J, Schmidt MH, Guilbert M, Martino A. Ligatures vasculaires en obstétrique dans les hémorragies sévères de la délivrance. Revue de la littérature. J Gynecol Obstet Biol Reprod 2002; 31: 629-39.
19. Lédée N, Ville Y, Musset D, Mercier F, Frydman R, Fernandez H. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Europ J Obstet Gynecol 2001; 94: 189-96.
20. Mussali GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000; 20: 331-4.
21. Gupta D, Sinha R. Management of placenta accreta with oral methotrexate. Int J Gynecol Obstet 1998; 60: 171-3.
22. Raziel A, Golan A, Ariely S, Herman A, Caspi E. Repeated ultrasonography and intramuscular methotrexate in the conservative management of residual adherent placenta. J Clin Ultrasound 1992; 20: 288-90.
23. Buckshee K, Dadhwal. Medical management of placenta accreta. Int J Gynecol Obstet 1997; 59: 47-8.
24. Jimenez-Caraballo A, Rodriguez-Donoso G. A 6-year clinical trial of methotrexate therapy in the treatment of ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 79: 167-71.
25. Jaffe R, DuBeshter B, Sherer DM, Thompson EA, Woods JR. Failure of methotrexate for term placenta percreta. Am J Obstet Gynecol 1994; 171: 558-9.
26. Deux JF, Bazot M, Le Blanche AF, Tassart M, Khalil A, Berkane N et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage? Am J Roentgenol 2001; 177: 145-9.
27. Shashoua AR, Stringer NH, Pearlman JB, Behmaram B, Stringer EA. Ischemic uterine rupture and hysterectomy 3 months after uterine artery embolization. J Am Assoc Gynecol Laparosc 2002; 9: 217-20.